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Statistical Analysis of Data in Mutagenicity
Assays: Rodent Micronucleus Assay
by M. Hayashi,' S. Hashimoto,2 Y. Sakamoto,3
C. Hamada,4 T. Sofuni,' and 1. Yoshimura5
Toevaluatechemicalsafety, manykindsofshort-termmutagenicity assaysareperformedtogetherwithlong-termassays
inanimals. Rationalesandmethodology fortheseassayshavebeenwell discussed and documented. Nositial method,
however, hasbeensingledoutasthemethodofchoicefortheevaluationofmutagenicityassaydata, althoughanumber
of reports on statistical methods to evaluate such data have been published. Among the mutagenicity assays, the
micronucleusassayusingmousebonemarrowerythropoieticcellshavebeenwidelyusedtoassesscytogeneticactivities
oftestchemicals. Astatistical evaluationprocedure forthisassayisproposedherein,combiningtheuseofhistoricalcontrol
dataanddose-response relationships. TheprobabilityoftypeIerrorsandthepowerofthismethodarecomparedwith
those ofsome otherconventional methodsbyMonteCarlosimulation.
Introduction
Several publishedguidelines formutagenicity studies require
appropriate statistical treatmentofassaydata. Althoughthere are
a large number ofpublications on the statistical evaluation of
mutagenicity test data, no one method is recommended exclu-
sively. Many ofthe methods are statistically validated buttoxi-
cologically impractical. Thus, manyempiricalmethods arestill
used fordataevaluation. This situation may beattributable to in-
adequatecommunicationbetweenbiologistsandstatisticians. An
attemptatimprovementhasbeenmadebytheU.K. Environmen-
tal MutagenSociety, and anoverviewandrecommendationshave
been published (1).
Many kindsofmutagenicity assayshavebeenperformed inthe
course of safety assessments of chemicals. Gene mutation,
chromosomal aberration, and DNAmodification aremainend
points. The micronucleus assay, an in vivo chromosomal aber-
ration assay, is targeted here to establish a statistical evaluation
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procedure that is practical and should be readily accepted by
biologists (2).
MicronucleusAssay
MaleddYmice, 8weeksold, wereusedforthemicronucleus
assay. Theexperimentconsistedofatleastthreedosegroupsand
concurrentnegativeandpositivecontrolgroups. Eachgrouphad
sixmice. Thehighestdoselevelandthesamplingtimes, which
werethemostimportantfactorsintheassay, wereoptimizedex-
perimentally(3). Secondandthirddoselevelswereone-halfand
one-quarter of the highest dose level, respectively. After
chemicaltreatment, micewerekilledandfemoralmarrowcells
were smeared on clean glass slides, fixed with methanol for 5
min at roomtemperature, and stainedwith Giemsaoracridine
orange (4). The frequencies ofmicronucleated polychromatic
erythrocytes (MNPCEs; young erythrocytes with one or more
micronuclei) werescoredmicroscopically basedonanobserva-
tionof 1000polychromatic erythrocytes (PCEs) peranimal.
Characteristics oftheMicronucleus Assay Data
The characteristics ofdata obtained from the micronucleus
assay areas follows: a)ThefrequencydistributionofMNPCE,
thetargetcellbeinganalyzed, isbinomial, atleastinthenegative
control groups (Fig. 1). b) Thehistorical negativeandpositive
controldatacanbeconstructedrelativelyeasily. Controlcharts
ofMNPCEdata from negativeandpositivecontrol groups ac-
cumulatedattheNationalInstituteofHygienicSciences,Tokyo,
areshown inFigures2 and3, respectively. c) Eachchemical is
assayedatatleastthreedoselevels,toassessadose-responserela-
tionship;d)Itisnotdifficulttorepeattheassay iftheresultsare
marginal orproblematic,unlikelong-termanimalexperiments.HAYASHIETAL.
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FIGURE 1. The distribution of frequency of micronucleated polychromatic
erythrocytes (PCEs) based on 1000 PCEs observation in the negative
historical control (bars), the fittedbinomial distributionB(0.002, 1000) (L),
and binomial random numbers (0) (2).
Strategy ofthe Evaluation
First, theconcurrentnegativeandpositivecontroldataaretested
to validate the assay system. Second, the treatment-induced
response is evaluated for each dose group. Third, the dose-
responserelationship isassessed. Thisstrategy iscomparableto
thatoftheempiricalevaluationprocessusedbybiologistsintox-
icological studies.
Proposed Procedure
Theprocedureconsistsofthefollowingthreesteps(Fig. 4)and
accepts as significant anoverallp-value of 5 0.01.
Step 1. Theconcurrentnegativeandpositivecontrolsarecom-
pared with the historical control. If the mean frequency of
MNPCEs deviates from the historical mean by >3 standard
deviations, the experiment is discounted and a new one is per-
formed for the same chemical.
Step 2. After passing step 1, the observed frequencies of
MNPCEs intreatment groups arecomparedwiththefrequency
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distribution ofthe negative historical control at a significance
level of0.05 divided by the number ofdose groups. Ifno dose
groupshowssignificantdifference, thetestchemical isclassified
as negative.
Step3. Ifthetestchemicalisnotclassifiedasnegativein step
2, the monotonous dose-response relationship is tested by the
Cochran-Armitagetrendtestusingtheconcurrentnegativecon-
trol atthenominal significancelevel of0.05. Thetestchemical
isclassifiedaspositiveonlywhenapositivedose-responserela-
tionship is shown.
Evaluationofthe Procedure
Type I errors and statistical power were compared by the
Monte Carlo method among four statistical methods: the
Cochran-Armitage trend test [significance level: 0.01 (5,6)]; a
binomial test (significancelevel: 0.01/numberofdosegroups);
conditionalbinomial test[significance level: 0.01 (7)1; andthe
proposedthree-stepmethod [significance level: 0.05/(numberof
dose groups) for step2, 0.05 for step 3, and0.01 overall (2) ].
WhentypeIerrorwas simulatedagainstthenumberofmice
pergroup, theCochran-Armitagetrendtestshowedalmostcon-
stanttypeIerrornearthenominallevel(Fig. 5). Althoughtype
Ierrorsoftheothermethodswerenotexactlycontrolledat0.01,
theprobabilitieswerecomparableamongthefourmethods. The
statistical powers of the methods were simulated with four
groups. Thedoses were setasd0, d,, d2, d3 = 0, 1, 2, 4 mg/kg.
Thepopulation proportionsofMNPCEs were setas wo, 7rI, 7r2,
7r3 = 0.2, 0.25, 0.3, 0.4%. The number ofmice per group was
set as 2-10. The simulated powers of the four methods were
ranked as binomial test > three-step method > > Cochran-
Armitage trend test > conditional binomial test(Fig. 6).
Theexperimentcouldberejectediftheconcurrentcontroldata
(e.g., step 1 ofthethree-stepmethod)deviatedgreatlyfromthe
historical controldata, depending onthe currentexperimental
conditions. Whenthedeviationwassmall, however, therobust-
ness of the method was important. When data were biased
downwardby 10%, i.e., whenthefrequenciesofMNPCEsinall
groups were lowered 10% from the expected values (based on
historical data), the power of the three-step method was the
highest(Fig. 7) in spiteofthedecreaseofatypeIerror. Onthe
otherhand, whendatawerebiasedupwardby 10% (Fig. 8), the
binomial test showed the highest power, with the three-step
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FIGURE 2. Acontrol chartofthehistorical dataoftheproportionofmicronucleatedpolychromatic erythrocytesinthenegativecontrol groupsusing six mice per
groupduringtheperiodfrom 1981 to 1986(2). C, 0.5% carboxymethyl cellulose sodiumsaltaqueoussolution; D, dimethylsulfoxide; N, notreatment; 0, olive
oil; S. physiological saline; W, distilled water.
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FIGURE 3. A control chart of the historical data of the proportion of
micronucleated polychromatic erythrocytes inthepositivecontrol groups us-
ingsixmice per groupduringtheperiodfrom 1981 to 1986(2). Micereceived
mitomycin C once IP at adoseof2 mg/kg and were killed24 or30hrafter
treatment.
method as aclose second; moreover, theincreaseoftypeI error
for the three-step method was not as great as thebinomial test.
Although the type I error for the Cochran-Armitage trend test
was constant and nominal even whendata were biased in both
directions, the powerofthismethod, aswell asoftheconditional
binomial test, was lower than that ofthe binomial test or the
three-step method.
The strategyoftheproposedthree-stepmethodispractical and
shouldbereadily accepted by toxicologists. Theresults concur
with toxicological judgment (2). For the overall evaluation of
micronucleus testdata, reproducibility isalsoimportant. Ifthe
resultsofthestatistical evaluationdisagreewiththeintuition of
the investigator, an additional experiment is recommended to
confirm the test result.
Prerequisites toapplytheproposedthree-step method are as
follows: a) negative andpositive historical controldata mustbe
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FIGURE 5. The probability of a type I error in experiments with three dose
groupsand anegativecontrol group (2). (L) Cochran-Armitagetrend test
[significancelevel: 0.01 (5,6)] (0)binomial test(significancelevel: 0.01/no.
ofdosegroups); (A)conditionalbinomial test[significance level: 0.01 (7)];
(-) the proposed three-step method (significance level: 0.05/no. of dose
groups for step 2, 0.05 for step 3, and 0.01 overall).
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FIGURE 6. The power of the four methods in experiments with three dose
groupsand anegativecontrol group (2). ([) Cochran-Armitagetrend test
[significance level: 0.01 (5,6)1 (0)binomial test(significancelevel: 0.01/no.
ofdosegroups); (A) conditionalbinomial test [significance level: 0.01 (7)];
(@) the proposed three-step method (significance level: 0.05/no. of dose
groups for step 2, 0.05 for step 3, and 0.01 overall).
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FIGURE 4. Strategy oftheevaluationofthemicronucleus assaydata. Firststep:
theconcurrentnegativeandpositivecontroldataaretestedtovalidatetheassay
system itself, and, ifit is not acceptable, a new experiment should be per-
formed. Secondstep: datafromeachdosegroupareevaluatedtodetermine
the increaseofresponsecomparedwiththehistorical control. Thirdstep: the
dose-response relationship isassessed. Aftertesting thesesteps, chemicals
would bedeclared negative orpositive inthe micronucleus assay.
FIGURE 7. The power of the four methods in experiments with three dose
groups and a negative control group biased downward by 10% (2). ([1)
Cochran-Armitagetrend test[significance level: QOL (t,6)J (0) binomial test
(significance level: 0.01/no. ofdosegroups); (A) conditional binomial test
[significance level: 0.01 (7)]; (-) the proposed three-step method
(significancelevel: 0.05/no. ofdosegroups forstep2, 0.05 forstep3, and 0.01
overall).
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FIGURE 8. The power of the four methods in experiments with three dose
groups and a negative control group biased upward by 10% (2). (L)
Cochran-Armitage trend test [significance level: 0.01 (5,6)] (0) binomial
test (significance level: 0.01/no. ofdosegroups); (A)conditionalbinomial
test [significance level: 0.01 (7)]; (@) the proposed three-step method
(significancelevel: 0.05/no. ofdosegroups forstep2,0.05 forstep3, and
0.01 overall).
available forthe relevant mouse strain, and thedistribution of
the negative control is binomial. b) For every new chemical,
doselevelsandsamplingtimesmustbeoptimized, possiblyby
a dose-and sampling-time-finding pilot experiment. c) Slides
should be coded and examined without any knowledge about
treatment, preferably by the same investigator(s). d) The fre-
quency of MNPCEs should be based on the observation of
at least 1000 PCEs peranimal. e) Both negative and positive
control groups mustbe included in anexperiment.
It is most important that the test results are credible and
reliabletechnicallyandbiologically. Afterstatistical evaluation
ofdata, theresultsofanexperimentareofteninterpretedasfact.
Butstatisticalmethodscannotevaluatethequalityofthedata,and
theymightleadtotheimpressionthattherewerenoproblemsin
thedata. Therefore, itistheresponsibilityofexperimentaltox-
icologists togenerate reliable data for statistical analyses.
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